글로벌리더십 Final Team Project

목차

Ⅰ. Introduction

Ⅱ-1. International Position and Issue
1) United State of America(US)
2) China
3) South Korea
4) WHO(the World Health Organization)
Ⅱ-2. Current problem of vaccine development

Ⅲ. Solutions
1) Past cases
2) Efforts currently being made internationally
3) Social efforts
4) Personal efforts

Ⅳ.Conclusion

Ⅴ. Sources

Ⅵ. Reflective team report

본문내용

Ⅰ. Introduction
The rapidly spreading coronavirus puts the world in a pandemic situation. The death toll continues to rise, meaning a global public health crisis affecting all parts of the world. The only way to end the current COVID-19 pandemic is to obtain collective immunity through effective vaccine development. As it is a problem facing the world, the development of the COVID-19 vaccine is the most urgent global health problem, solidarity and cooperation around the world are critical for rapid and safe vaccine development. So the report will deal with the current international problem situation in the course of vaccine development and how to solve and cooperate with it.

Ⅱ-1. International Position and Issue
1) United State of America(US)
Remdesivir, known as the anti-coronaviral drug used for emergency only in the US since May, have been given full approval for use in almost patients for treatment in hospitals by US regulators(FDA).

참고자료

· who: the push for a covid-19 vaccine
· WHO: Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time(15 october 2020)
· medRxiv: repurposed antiviral drugs for COVID-19 -interim WHO SOLIDARITY trial results. doi:https://doi.org/10.1101/2020.10.15.20209817 WHO. Registration: ISRCTN83971151, NCT04315948) (15 october 2020ver.)
· BBC news: Covid: US gives full approval for antiviral remdesivir drug(2020.10.24.)
· BBC news: Dexamethasone, remdesivir, Regeneron: Trump's Covid treatment explained (2020.10.9.)
· BBC news: Coronavirus vaccine: When will we have one?(2020.10.28.)
· Nature :What China’s speedy COVID vaccine deployment means for the pandemic. nature 586, 343-344 (2020). doi: https://doi.org/10.1038/d41586-020-02807-2
· S&P Global market intelligence : Sinovac, Sinopharm COVID-19 vaccines approved for China emergency use – Reuters(28 Aug, 2020)
· Time news: You Can Now Get a COVID-19 Vaccine in China. That Might Not Be a Good Thing (2020. 10.22)
· YONHAP news : S. Korean bio firms in race for COVID-19 treatment, vaccine development(202. 10. 03)
· KF(Korea Foundation): KF 코로나19 백신개발 동향 및 국제인적교류전망, KF vol.1 (2020. 10)
· Interactions between Actors in the Global Vaccine Governance: States, IGOs, and Non-state Actors/HanSeung Cho/2018, vol.36, no.1, pp. 3-30 (28 pages)
· U.S. says it won’t join WHO-linked effort to develop, distribute coronavirus vaccine /By Emily Rauhala and Yasmeen Abutaleb / September 2, 2020 / www.washingtonpost.com
· Junhewk Kim, 2020, [COVID-19, medical justice, medical resource allocation, luck egalitarianism, saving the most life-years]
· Naver Knowledge Bag and [Cobax Perfection]
· WHO COVAX Facility https://www.who.int/countries
· Korea Health Industry Promotion Agency Research Report Medical Service
· 정준호,김옥주(2020), Research of Ethics in COVID-19(SARS-CoV-2) Vaccine Study, 생명윤리정책연구 Vol.13 No.3, 1-25 pages.